0001562180-19-003124.txt : 20190528
0001562180-19-003124.hdr.sgml : 20190528
20190528160452
ACCESSION NUMBER: 0001562180-19-003124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190523
FILED AS OF DATE: 20190528
DATE AS OF CHANGE: 20190528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandor Victor
CENTRAL INDEX KEY: 0001620368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 19857691
MAIL ADDRESS:
STREET 1: C/O ARRAY BIOPHARMA INC.
STREET 2: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-05-23
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001620368
Sandor Victor
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET
BOULDER
CO
80301
false
true
false
false
Chief Medical Officer
Common Stock
2019-05-23
4
M
false
40634.00
3.65
A
278326.00
D
Common Stock
2019-05-23
4
S
false
40634.00
26.5011
D
237692.00
D
Common Stock
2019-05-28
4
M
false
46766.00
3.65
A
284458.00
D
Common Stock
2019-05-28
4
S
false
74915.00
27.003
D
209543.00
D
Stock Option (Right to Buy)
3.65
2019-05-23
4
M
false
40634.00
0.00
D
2024-09-22
Common Stock
40634.00
98628.00
D
Stock Options (Right to buy)
3.65
2019-05-28
4
M
false
46766.00
0.00
D
2024-09-22
Common Stock
46766.00
51862.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan.
The price reported for these shares is the weighted average sale price of transactions made at prices from $26.50 to $26.51. Details of actual prices for shares sold are available from the Issuer upon request.
The price reported for these shares is the weighted average sale price of transactions made at prices from $26.75 to $27.10. Details of actual prices for shares sold are available from the Issuer upon request.
The option vested in four equal annual installments beginning on September 22, 2015.
Jason Haddock, attorney-in-fact for Victor Sandor
2019-05-28